{"type":"rich","title":"Pimavanserin Pharmacology Podcast","version":"1.0","provider_name":"Blubrry","provider_url":"https://blubrry.com","author_name":"Real Life Pharmacology - Pharmacology Education for Health Care Professionals","html":"<iframe src=\"https://player.blubrry.com/?podcast_id=151069961\" title=\"Blubrry Podcast Player\" scrolling=\"no\" width=\"100%\" height=\"230\" frameborder=\"0\"></iframe>","height":"230","description":"Pimavanserin is an atypical antipsychotic approved for the treatment of hallucinations and delusions associated with Parkinson&#8217;s disease psychosis. Unlike traditional antipsychotics, it does not block dopamine receptors, making it a unique option fo","thumbnail_url":"https://assets.blubrry.com/coverart/160/542381.jpg"}